Nurse Practitioner · Peoria, IL
NPI
1215301221
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1001 Main St Ste 400
Peoria, IL, 61606
Phone (309) 308-0900
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
640 services
Medicare patients, 2024
195
Average age 70
Drug cost, 2024
$2.8M
4,221 prescriptions
Company payments, 2025
$285
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory Garmon was code 83036 (blood count), 279 times for 161 patients. In total Gregory Garmon billed 640 services in 11 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83036 Blood Count | Office | 279 | 161 | $9.52 | $2,656 |
| 99213 Office E&M - Established | Office | 215 | 150 | $49.59 | $11K |
| 99214 Office E&M - Established | Office | 88 | 76 | $66.22 | $5,827 |
| 99215 Office E&M - Established | Office | 35 | 29 | $94.39 | $3,304 |
By year: 2022 $35K for 798 services; 2023 $34K for 720 services; 2024 $24K for 640 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 279 | 161 | $9.52 | $2,656 |
Medicare prescription drug claims, 2024
In 2024, the drug Gregory Garmon prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 354 prescriptions and refills. In total Gregory Garmon wrote 4,221 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 354 | 429 | 67 | $445K |
| Metformin Hcl Generic | 278 | 657 | 77 | $2,062 |
| Tresiba Flextouch U-200 Insulin Degludec | 205 | 368 | 50 | $324K |
| Jardiance Empagliflozin | 200 | 458 | 58 | $260K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 200 | 413 | 68 | $36K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 172 | 418 | 59 | $18K |
| Ozempic Semaglutide | 155 | 251 | 52 | $236K |
| Metformin Hcl Er Metformin Hcl | 141 | 386 | 53 | $1,412 |
| Novolog Flexpen Insulin Aspart | 121 | 197 | 52 | $40K |
| Humalog Kwikpen U-100 Insulin Lispro | 98 | 152 | 29 | $44K |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 97 | 180 | 29 | $202K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 94 | 221 | 32 | $9,481 |
| Trulicity Dulaglutide | 89 | 102 | 19 | $98K |
| Tresiba Flextouch U-100 Insulin Degludec | 84 | 192 | 27 | $57K |
| Glimepiride Generic | 83 | 214 | 24 | $568 |
Brand drugs: 2,513 claims; generic drugs: 995 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory Garmon $285 ($285 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $242.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.